Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment of non-small-cell lung cancer and pharmacogenomics: where we are and where we are going.

Current opinion in oncology - 1 Mar 2006

Rosell Rafael, Cuello Mauricio, Cecere Fabiana, Santarpia Mariacarmela, Reguart Noemi, Felip Enriqueta, Taron Miquel

Abstract excerpt

PURPOSE OF REVIEW: This review highlights the numerous molecular biology findings in the field of lung cancer with potential therapeutic impact in both the near and distant future. RECENT FINDINGS: Abundant preclinical and clinical data indicate that BRCA1 mRNA expression is a differential modulator of chemotherapy sensitivity. Single nucleotide polymorphisms in the excision repair cross-complementing 1 gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Drug Resistance, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endonucleases

Share to Estrogens

Share to Genes, BRCA1

Share to Genes, Neoplasm

Share to Neoplasm Proteins

Share to Up-Regulation

Source

Identifiers

PMID: 16462182
DOI: 10.1097/01.cco.0000208786.91947.eb

Genes

EGFR
BRCA1
ERCC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment of non-small-cell lung cancer and pharmacogenomics: where we are and where we are going.PMID 16462182Read ↗

The place of targeted therapies in the management of non-small cell bronchial carcinoma. Molecular markers as predictors of tumor response and survival in lung cancer.Semantic proximity Read ↗

Optimization of genetics to create therapies for metastatic (stage IV) non-small-cell lung cancer.Semantic proximity Read ↗

Usefulness of predictive tests for cancer treatment.Semantic proximity Read ↗

Molecular Predictors of Response to Chemotherapy in Non-Small Cell Lung CancerSemantic proximity Read ↗

From the bench to the bed: individualizing treatment in non-small-cell lung cancer.Semantic proximity Read ↗

Nucleotide Excision Repair Pathways Involved in Cisplatin Resistance in Non-Small-Cell Lung CancerSemantic proximity Read ↗

Molecular Analysis-Based Treatment Strategies for the Management of Non-small Cell Lung CancerSemantic proximity Read ↗

The Impact of Genomic Profiling for Novel Cancer Therapy--Recent Progress in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Pharmacogenomics and targeted therapy of cancer: Focusing on non-small cell lung cancer.Semantic proximity Read ↗

The Genomics of Lung Adenocarcinoma: Opportunities for Targeted TherapiesSemantic proximity Read ↗

New Targets in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.